Zhengye Biotechnology Holding Limited (ZYBT)

Market Cap	216.49M
Revenue (ttm)	26.11M
Net Income (ttm)	2.79M
Shares Out	47.17M
EPS (ttm)	0.06
PE Ratio	79.50
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	555,959
Open	4.810
Previous Close	4.860
Day's Range	4.140 - 5.850
52-Week Range	3.700 - 6.100
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About ZYBT

Zhengye Biotechnology Holding, through its operating entity, focus on the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. For nearly 20 years, the operating entity has been committed to enhancing the health of livestock by offering a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The operating entity’s products are available in 29 provincial regions across China and are exported overseas, to Vietnam, Pakistan, and Egypt.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Jan 7, 2025
• Employees: 286
• Stock Exchange: NASDAQ
• Ticker Symbol: ZYBT
• Website: https://www.jlzybio.com/

Financial Performance

Financial numbers in CNY